United States Biotechnology & Medical Research

Ironwood Pharmaceuticals Inc (IRWD)

Track

Ironwood Pharmaceuticals Inc. experienced four insider trading transactions over the past ninety days, all involving sales. These divestments occurred following the company's August 2026 results financiers. Executives and directors offloaded shares, reflecting a trend of liquidation rather than acquisition, while the stock price maintained a modest gain of 2.2% during this period.
Ticker: IRWD Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ironwood Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 7 Jul 2026
Value US$4,618,688.26 | Price 197.41 | Shares 40,241 (+8.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-09 2026-07-07 PlS Planned sale
4.0
Silver Ronald

PFO & PAO

Officer
40,241 +8.0%
197.41
US$4,618,688 		40,241 +8.0% 197.41 US$4,618,688
2026-07-07 2026-07-07 PrS Proposed sale
4.0
RONALD SILVER

Officer

Officer
37,954
353.33
US$4,007,157 		37,954 353.33 US$4,007,157
2026-06-17 2026-06-16 PlS Planned sale
0.9
McHugh Julie
Non-Executive Director
796 +40.9%
122.01
US$1,092,007 		796 +40.9% 122.01 US$1,092,007
2026-06-16 2026-06-16 PrS Proposed sale
0.9
JULIE MCHUGH

Director

Non-Executive Director
21,571
3.69
US$79,597 		21,571 3.69 US$79,597
2026-03-17 2026-03-17 S Sale
2.8
DENNER ALEXANDER J
Non-Executive Director
5,800 -0.1%
3.31
US$19,198 		5,800 -0.1% 3.31 US$19,198
2026-03-17 2026-03-17 S Sale
2.8
DENNER ALEXANDER J
Non-Executive Director
6,725,000 -42.2%
3.05
US$20,511,250 		6,725,000 -42.2% 3.05 US$20,511,250
2026-02-25 2026-02-24 S Sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
12,621 -4.8%
3.66
US$46,193 		12,621 -4.8% 3.66 US$46,193
2026-02-25 2026-02-24 S Sale
3.1
Martini Gregory S.

Chief Financial Officer

Officer
11,457 -6.7%
3.66
US$41,933 		11,457 -6.7% 3.66 US$41,933
2026-02-25 2026-02-24 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
19,053 -5.0%
3.66
US$69,734 		19,053 -5.0% 3.66 US$69,734
2026-02-25 2026-02-24 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
103,526 -6.5%
3.66
US$378,905 		103,526 -6.5% 3.66 US$378,905
2026-02-25 2026-02-24 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
11,239 -5.0%
3.66
US$41,135 		11,239 -5.0% 3.66 US$41,135
2026-02-25 2026-02-23 S Sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
11,552 -4.2%
3.81
US$44,013 		11,552 -4.2% 3.81 US$44,013
2026-02-25 2026-02-23 S Sale
4.1
Shetzline Michael

SVP, CMO, Head-Res&Drug

Officer
15,570 -2.8%
3.81
US$59,322 		15,570 -2.8% 3.81 US$59,322
2026-02-25 2026-02-23 S Sale
3.1
Martini Gregory S.

Chief Financial Officer

Officer
10,487 -5.7%
3.81
US$39,955 		10,487 -5.7% 3.81 US$39,955
2026-02-25 2026-02-23 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
17,439 -4.4%
3.81
US$66,443 		17,439 -4.4% 3.81 US$66,443
2026-02-25 2026-02-23 PlS Planned sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
94,757 -5.6%
3.81
US$361,024 		94,757 -5.6% 3.81 US$361,024
2026-02-25 2026-02-23 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
10,287 -4.4%
3.81
US$39,193 		10,287 -4.4% 3.81 US$39,193
2026-02-20 2026-02-23 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
19,775
4.61
US$91,163 		19,775 4.61 US$91,163
2026-02-20 2026-02-23 PrS Proposed sale
3.1
Martini Gregory S.

Officer

Officer
20,163
4.61
US$92,951 		20,163 4.61 US$92,951
2026-02-20 2026-02-23 PrS Proposed sale
4.1
Shetzline Michael

Officer

Officer
29,937
4.61
US$138,010 		29,937 4.61 US$138,010
2026-02-20 2026-02-23 PrS Proposed sale
4.2
John Minardo

Officer

Officer
33,528
4.61
US$154,564 		33,528 4.61 US$154,564
2026-02-20 2026-02-23 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
182,185
4.61
US$839,873 		182,185 4.61 US$839,873
2026-01-07 2026-01-05 PlS Planned sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
35,416 -11.3%
4.60
US$162,914 		35,416 -11.3% 4.60 US$162,914
2026-01-05 2026-01-05 PrS Proposed sale
4.0
RONALD SILVER

Officer

Officer
35,416
4.27
US$151,226 		35,416 4.27 US$151,226
2025-11-19 2025-11-17 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
6,016 -2.5%
3.32
US$19,973 		6,016 -2.5% 3.32 US$19,973
2025-11-14 2025-11-17 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
6,324
3.37
US$21,312 		6,324 3.37 US$21,312
2025-08-13 2025-08-11 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
1,316 -0.5%
0.84
US$1,105 		1,316 -0.5% 0.84 US$1,105
2025-08-13 2025-08-11 S Sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
2,846 -1.0%
0.84
US$2,391 		2,846 -1.0% 0.84 US$2,391
2025-08-13 2025-08-11 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
7,754 -1.9%
0.84
US$6,513 		7,754 -1.9% 0.84 US$6,513
2025-08-13 2025-08-11 S Sale
3.1
Martini Gregory S.

Chief Financial Officer

Officer
1,265 -0.7%
0.84
US$1,063 		1,265 -0.7% 0.84 US$1,063
2025-08-08 2025-08-11 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
1,406
0.88
US$1,237 		1,406 0.88 US$1,237
2025-08-08 2025-08-11 PrS Proposed sale
3.1
Martini Gregory S.

Officer

Officer
1,351
0.88
US$1,189 		1,351 0.88 US$1,189
2025-08-08 2025-08-11 PrS Proposed sale
4.2
John Minardo

Officer

Officer
8,281
0.88
US$7,287 		8,281 0.88 US$7,287
2025-05-16 2025-05-19 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
2,814
0.59
US$1,660 		2,814 0.59 US$1,660
2025-05-16 2025-05-19 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
14,661
0.59
US$8,650 		14,661 0.59 US$8,650
2025-05-20 2025-05-16 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
13,353 -1.2%
0.58
US$7,745 		13,353 -1.2% 0.58 US$7,745
2025-05-20 2025-05-16 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
2,563 -1.0%
0.58
US$1,487 		2,563 -1.0% 0.58 US$1,487
2025-02-12 2025-02-10 S Sale
4.1
Shetzline Michael

SVP, CMO, Head-Res&Drug

Officer
41,269 -6.9%
1.76
US$72,633 		41,269 -6.9% 1.76 US$72,633
2025-02-12 2025-02-10 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
139,064 -10.7%
1.76
US$244,753 		139,064 -10.7% 1.76 US$244,753
2025-02-12 2025-02-10 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
38,938 -8.7%
1.76
US$68,531 		38,938 -8.7% 1.76 US$68,531
2025-02-12 2025-02-10 S Sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
12,048 -4.1%
1.76
US$21,204 		12,048 -4.1% 1.76 US$21,204
2025-02-12 2025-02-10 S Sale
3.1
Martini Gregory S.

Chief Financial Officer

Officer
12,052 -6.2%
1.76
US$21,212 		12,052 -6.2% 1.76 US$21,212
2025-02-07 2025-02-10 PrS Proposed sale
3.1
Martini Gregory S.

Officer

Officer
12,347
1.94
US$23,953 		12,347 1.94 US$23,953
2025-02-07 2025-02-10 PrS Proposed sale
4.2
John Minardo

Officer

Officer
39,889
1.94
US$77,385 		39,889 1.94 US$77,385
2025-02-07 2025-02-10 PrS Proposed sale
4.1
Shetzline Michael

Officer

Officer
42,274
1.94
US$82,012 		42,274 1.94 US$82,012
2025-02-07 2025-02-10 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
142,454
1.94
US$276,361 		142,454 1.94 US$276,361
2024-12-27 2024-12-27 PrS Proposed sale
3.7
Davis Andrew

Officer

Officer
60,434
4.00
US$241,736 		60,434 4.00 US$241,736
2024-11-20 2024-11-18 S Sale
2.2
Emany Sravan Kumar

SVP, COO and CFO

Officer
11,001 -3.4%
4.08
US$44,884 		11,001 -3.4% 4.08 US$44,884
2024-11-20 2024-11-18 PlS Planned sale
3.7
Davis Andrew

SVP, Chief Business Officer

Officer
5,360 -1.8%
4.08
US$21,869 		5,360 -1.8% 4.08 US$21,869
2024-11-15 2024-11-18 PrS Proposed sale
3.7
Davis Andrew

Officer

Officer
6,090
4.11
US$25,030 		6,090 4.11 US$25,030
2024-11-15 2024-11-18 PrS Proposed sale
2.2
Emany Sravan Kumar

Officer

Officer
12,500
4.11
US$51,375 		12,500 4.11 US$51,375
2024-08-14 2024-08-12 S Sale
4.0
Silver Ronald

Principal Accounting Officer

Officer
3,107 -1.9%
4.27
US$13,267 		3,107 -1.9% 4.27 US$13,267
2024-08-14 2024-08-12 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
9,910 -3.4%
4.27
US$42,316 		9,910 -3.4% 4.27 US$42,316
2024-08-09 2024-08-12 PrS Proposed sale
4.2
John Minardo

Officer

Officer
11,726
4.05
US$47,490 		11,726 4.05 US$47,490
2024-06-12 2024-06-10 PlS Planned sale
0.9
McHugh Julie
Non-Executive Director
22,766 -14.0%
6.29
US$143,198 		22,766 -14.0% 6.29 US$143,198
2024-06-10 2024-06-10 PrS Proposed sale
0.9
JULIE MCHUGH

Director

Non-Executive Director
22,766
6.35
US$144,564 		22,766 6.35 US$144,564
2024-06-10 2024-06-07 S Sale
3.6
Moukheibir Catherine
Non-Executive Director
35,574 -42.2%
6.61
US$235,144 		35,574 -42.2% 6.61 US$235,144
2024-06-07 2024-06-07 PrS Proposed sale
3.6
Moukheibir Catherine

Director

Non-Executive Director
35,574
6.60
US$234,767 		35,574 6.60 US$234,767
2024-06-10 2024-06-06 S Sale
3.6
Moukheibir Catherine
Non-Executive Director
44,426 -34.5%
6.36
US$282,549 		44,426 -34.5% 6.36 US$282,549
2024-06-06 2024-06-06 PrS Proposed sale
3.6
Moukheibir Catherine

Director

Non-Executive Director
44,426
6.36
US$282,490 		44,426 6.36 US$282,490
2024-05-22 2024-05-20 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
17,404 -5.6%
6.45
US$112,256 		17,404 -5.6% 6.45 US$112,256
2024-05-22 2024-05-20 S Sale
3.7
Davis Andrew

SVP, Chief Business Officer

Officer
22,725 -7.3%
6.45
US$146,576 		22,725 -7.3% 6.45 US$146,576
2024-05-22 2024-05-20 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
67,618 -5.6%
6.45
US$436,136 		67,618 -5.6% 6.45 US$436,136
2024-05-22 2024-05-20 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
67,618 -5.6%
6.45
US$436,136 		67,618 -5.6% 6.45 US$436,136
2024-05-22 2024-05-20 S Sale
4.1
Shetzline Michael

CMO,SVP,Head-Res&Drug

Officer
16,128 -3.8%
6.45
US$104,026 		16,128 -3.8% 6.45 US$104,026
2024-05-22 2024-05-20 S Sale
4.1
Shetzline Michael

CMO,SVP,Head-Res&Drug

Officer
16,128 -3.8%
6.45
US$104,026 		16,128 -3.8% 6.45 US$104,026
2024-05-17 2024-05-20 PrS Proposed sale
3.7
Davis Andrew

Officer

Officer
25,105
6.64
US$166,697 		25,105 6.64 US$166,697
2024-05-17 2024-05-20 PrS Proposed sale
4.2
John Minardo

Officer

Officer
19,228
6.64
US$127,674 		19,228 6.64 US$127,674
2024-05-17 2024-05-20 PrS Proposed sale
4.1
Shetzline Michael

Officer

Officer
17,820
6.64
US$118,325 		17,820 6.64 US$118,325
2024-05-17 2024-05-20 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
74,705
6.64
US$496,041 		74,705 6.64 US$496,041
2024-03-08 2024-03-06 B Purchase
1.0
Duane Jon R
Non-Executive Director
6,920 +6.1%
8.70
US$60,204 		6,920 +6.1% 8.70 US$60,204
2024-03-06 2024-03-04 B Purchase
2.2
Emany Sravan Kumar

SVP, Chief Financial Officer

Officer
10,684 +3.7%
9.38
US$100,216 		10,684 +3.7% 9.38 US$100,216
2024-02-14 2024-02-12 S Sale
4.1
Shetzline Michael

CMO,SVP,Head-Res&Drug

Officer
38,618 -10.2%
15.24
US$588,538 		38,618 -10.2% 15.24 US$588,538
2024-02-14 2024-02-12 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
177,164 -17.5%
15.24
US$2,699,979 		177,164 -17.5% 15.24 US$2,699,979
2024-02-14 2024-02-12 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
47,380 -17.4%
15.24
US$722,071 		47,380 -17.4% 15.24 US$722,071
Explore more

More insider trading research around Ironwood Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America